iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Option Chain

1,564.6
(-1.88%)
Sep 1, 2025|12:04:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,360₹1 -20%55,6500%
--1,400₹2.7 25.58%3,81,15044.04%
--1,420₹3.85 32.75%18,2008.33%
1,0500%₹137.55 0%1,440₹5.4 52.11%1,21,80020.83%
1,0500%₹120 0%1,460₹7.3 56.98%66,15032.16%
4,9000%₹99.4 0%1,480₹10 61.29%84,000-2.83%
35,0007.52%₹84 -21.86%1,500₹13.75 65.66%6,64,3002.09%
18,90025.58%₹67.4 -25.02%1,520₹18.2 71.69%79,45086.06%
27,65097.5%₹54.05 -26.81%1,540₹24.45 68.62%3,11,50047.10%
63,35092.55%₹41.15 -30.66%1,560₹32 64.94%4,02,500200.26%
2,82,450371.92%₹30.75 -33.44%1,580₹41.3 57.63%2,42,20072.56%
7,70,000112.35%₹22.15 -36.62%1,600₹52.35 50.86%3,05,90015.45%
8,98,45071.24%₹15.45 -40.11%1,620₹65.9 44.2%88,9001.6%
3,68,90078.34%₹10.65 -42.43%1,640₹80.2 38.27%92,050-7.71%
3,59,80027.86%₹7.6 -42.2%1,660₹96.95 34.37%87,850-0.79%
1,62,40043.65%₹5.2 -44.08%1,680₹115 28.92%28,7000%
4,65,15030.03%₹3.65 -44.69%1,700₹130.25 21.95%88,2000%
55,30023.43%₹2.6 -44.68%1,720₹151.95 22.34%24,150-4.16%
76,650-1.35%₹1.95 -39.06%1,740₹168.55 11.36%15,75012.5%
1,00,1005.92%₹1.5 -38.77%1,760₹170.35 0%5,9500%
28,7007.89%₹1.25 -30.55%1,780--
1,53,6506.29%₹1.05 -25%1,800₹215.6 0%17,5000%
12,2502.94%₹1 -23.07%1,840--
6,3000%₹0.95 0%1,880₹294 0%10,1500%
32,90011.90%₹0.75 -21.05%1,920--

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 15th July 2025
15 Jul 2025|06:24 AM

Here are some of the stocks that may see significant price movement today: Power Mech Projects, Rail Vikas Nigam, Rallis India, etc.

Read More
Top Stocks for Today - 16th June 2025
16 Jun 2025|06:23 AM

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection
15 Jun 2025|11:50 PM

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal
24 May 2025|07:51 PM

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore
23 May 2025|12:07 PM

The Board recommended a final dividend of ₹5.50 per share for FY25.

Read More
Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.